Home › NDC Lookup › RxCUI directory › RxCUI 1723160

4 ML amikacin 250 MG/ML Injection — RxCUI 1723160

Name: 4 ML amikacin 250 MG/ML Injection (RxCUI 1723160)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1723160 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1723160

Official name4 ML amikacin 250 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asamikacin (as amikacin sulfate) 1 GM per 4 ML Injection; amikacin sulfate 1 GM in 4 ML Injection

FDA products mapped11

Package NDCs mapped14

Reported Medicaid activity (SDUD)2,869 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amikacin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Amikacin is reserved for serious, hard-to-treat bacterial infections — the kind that either don't respond to standard antibiotics or are caused by bacteria that are resistant to ot...
Why am I getting amikacin instead of a regular oral antibiotic?
This is really important to stay on top of. The tricky thing is that hearing damage from amikacin often starts at high frequencies that you can't notice in everyday conversations....
How will I know if amikacin is affecting my hearing?

📖 Read our full Amikacin Injection guide →

🕸️ Concept Web — How 4 ML amikacin 250 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 4 ML amikacin 250 MG/ML Injection RxCUI 1723160 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Amikacin 641 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Amikacin Injection 1723155 SCDF
- Amikacin Injectable Product 1151588 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Amikacin 250 MG/ML 1598046 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Amikacin 250 MG/ML SCDC · 1598046
Amikacin Injection SCDF · 1723155
Amikacin Injectable Product SCDG · 1151588

📦 FDA Products & Package NDCs

11 products · 14 package NDCs

14 package NDCs map to RxCUI 1723160 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00641-6166-10	10 VIAL in 1 CARTON (0641-6166-10) / 4 mL in 1 VIAL (0641-6...	Amikacin Sulfate	Hikma Pharmaceuticals USA Inc.	2015-08-01
00641-6167-10	10 VIAL, SINGLE-DOSE in 1 CARTON (0641-6167-10) / 2 mL in 1...	Amikacin Sulfate	Hikma Pharmaceuticals USA Inc.	2015-08-01
23155-0290-41	10 VIAL, GLASS in 1 CARTON (23155-290-41) / 2 mL in 1 VIAL,...	Amikacin Sulfate	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2013-12-24
23155-0290-42	10 VIAL, GLASS in 1 CARTON (23155-290-42) / 4 mL in 1 VIAL,...	Amikacin Sulfate	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2013-12-24
23155-0785-41	10 VIAL, GLASS in 1 CARTON (23155-785-41) / 2 mL in 1 VIAL,...	Amikacin Sulfate	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2020-12-15
23155-0786-41	10 VIAL, GLASS in 1 CARTON (23155-786-41) / 4 mL in 1 VIAL,...	Amikacin Sulfate	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	2020-12-15
25021-0173-02	10 VIAL in 1 CARTON (25021-173-02) / 2 mL in 1 VIAL	amikacin sulfate	Sagent Pharmaceuticals	2016-06-15
25021-0173-04	10 VIAL in 1 CARTON (25021-173-04) / 4 mL in 1 VIAL	amikacin sulfate	Sagent Pharmaceuticals	2016-06-15
63323-0815-02	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-815-02) / 2 mL in 1...	Amikacin Sulfate	Fresenius Kabi USA, LLC	2015-12-09
63323-0815-04	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-815-04) / 4 mL in 1...	Amikacin Sulfate	Fresenius Kabi USA, LLC	2015-12-09
67184-0569-02	10 VIAL, GLASS in 1 CARTON (67184-0569-2) / 2 mL in 1 VIAL,...	Amikacin Sulfate	Qilu Pharmaceutical Co., Ltd.	2024-03-19
67184-0570-02	10 VIAL, GLASS in 1 CARTON (67184-0570-2) / 4 mL in 1 VIAL,...	Amikacin Sulfate	Qilu Pharmaceutical Co., Ltd.	2024-03-19
83301-0022-02	10 VIAL, SINGLE-DOSE in 1 CARTON (83301-0022-2) / 2 mL in 1...	Amikacin Sulfate	Mullan Pharmaceutical Inc.	2026-01-12
83301-0023-02	10 VIAL, SINGLE-DOSE in 1 CARTON (83301-0023-2) / 4 mL in 1...	Amikacin Sulfate	Mullan Pharmaceutical Inc.	2026-01-12

Observed labelers: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (4) · Fresenius Kabi USA, LLC (2) · Hikma Pharmaceuticals USA Inc. (2) · Mullan Pharmaceutical Inc. (2) · Qilu Pharmaceutical Co., Ltd. (2) · Sagent Pharmaceuticals (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0278	Amikacin sulfate injection	12	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.